231 related articles for article (PubMed ID: 32914567)
1. Proanthocyanidin B2 inhibits proliferation and induces apoptosis of osteosarcoma cells by suppressing the PI3K/AKT pathway.
Wu X; Yu H; Zhou H; Li Z; Huang H; Xiao F; Xu S; Yang Y
J Cell Mol Med; 2020 Oct; 24(20):11960-11971. PubMed ID: 32914567
[TBL] [Abstract][Full Text] [Related]
2. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
3. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
Huang Y; Chen J; Yang S; Tan T; Wang N; Wang Y; Zhang L; Yang C; Huang H; Luo J; Luo X
Drug Des Devel Ther; 2020; 14():4625-4637. PubMed ID: 33154629
[TBL] [Abstract][Full Text] [Related]
4. Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway.
Liu M; Zhang J; Dong H; Wang W
J Cell Physiol; 2019 Nov; 234(11):20879-20887. PubMed ID: 31001861
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway.
Da W; Tao L; Zhu Y
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013357
[TBL] [Abstract][Full Text] [Related]
6. LY404039 Inhibits Proliferation and Metastasis of Osteosarcoma Cells via PI3K Signaling Pathway.
Wu S; Feng Z; Wei B; Jiang L
Ann Clin Lab Sci; 2019 May; 49(3):291-296. PubMed ID: 31308026
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
8. C₁₈H₁₇NO₆ Inhibits Invasion and Migration of Human MNNG Osteosarcoma Cells via the PI3K/AKT Signaling Pathway.
Qu Q; He Z; Jiang Y; Lu D; Long X; Ding Y; Xu B; He X
Med Sci Monit; 2019 Oct; 25():7527-7537. PubMed ID: 31589596
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
Eur J Pharmacol; 2019 Sep; 858():172477. PubMed ID: 31228450
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
11. Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway.
Zhu J; Sun Y; Lu Y; Jiang X; Ma B; Yu L; Zhang J; Dong X; Zhang Q
Cell Death Dis; 2018 Jun; 9(6):708. PubMed ID: 29899333
[TBL] [Abstract][Full Text] [Related]
12. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
13. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
[TBL] [Abstract][Full Text] [Related]
14. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
[TBL] [Abstract][Full Text] [Related]
15. ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway.
Li H; Shen X; Ma M; Liu W; Yang W; Wang P; Cai Z; Mi R; Lu Y; Zhuang J; Jiang Y; Song Y; Wu Y; Shen H
J Exp Clin Cancer Res; 2021 Oct; 40(1):340. PubMed ID: 34706747
[TBL] [Abstract][Full Text] [Related]
16. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
18. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways.
Tian W; Wang ZW; Yuan BM; Bao YG
Mol Med Rep; 2020 Jun; 21(6):2349-2356. PubMed ID: 32236598
[TBL] [Abstract][Full Text] [Related]
19. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
20. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
